Investors are ostensibly keeping Catalyst Pharmaceuticals' P...
Investors are ostensibly keeping Catalyst Pharmaceuticals' P/E high due to expectations of its future growth surpassing the market. Currently, shareholders are confident in future earnings and do not foresee a significant dip in the share price in the near future.
Why Investors Shouldn't Be Surprised By Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) P/E
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
Moomoo AI Official Account
Your AI assistant for discovering investment opportunities.
3259Followers
0Following
8027Visitors
Follow